Literature DB >> 27377523

The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.

Bernd Löwe1, Ansgar Lohse2, Viola Andresen3, Eik Vettorazzi4, Matthias Rose1,5, Wiebke Broicher1.   

Abstract

OBJECTIVES: It remains controversial whether psychosocial burden is an independent predictor of irritable bowel syndrome (IBS) or occurs concurrently as an epiphenomenon. Here we prospectively examine the individual contribution of psychosocial risk factors, demographic factors, somatic symptoms, and gastrointestinal infection within a non-clinical, IBS-free population before infection occurred.
METHODS: A prospective community-based cohort study including a consecutive sample of healthy participants with an elevated risk of developing gastrointestinal infection during long-distance travel was conducted. Potential predictive factors were investigated using validated self-report scales pre-travel, 1 week after return, and 7 months post-travel. IBS was assessed using the ROME-III Diagnostic Questionnaire.
RESULTS: Of the 1,964 eligible long-distance travelers, 1,464 responded at follow-up directly after their journey, and 1,190 participants completed the study 7 months post-journey. Fifty-three percent of study completers were female, mean age was 39.9 (s.d.=15.7) years. The mean travel duration was 40.8 (s.d.=52.8) days, and 43.3% (95% confidence interval (CI)=40.4-46.1%) of participants experienced at least moderate infectious travelers' diarrhea. The incidence of newly developed IBS 7 months post-travel was 7.2% (95%CI=5.8-8.6%). In multivariate analyses, female gender, vulnerability to diarrhea under stress, baseline somatic symptom burden, baseline illness anxiety, diarrhea within the 4 months pre-travel, and travelers' diarrhea during the journey significantly predicted IBS post-travel.
CONCLUSION: This study indicates that gastrointestinal infection as well as predisposing factors such as female gender, vulnerability to diarrhea under stress, illness anxiety, and somatic symptom burden predict the development of IBS. The results indicate the necessity of simultaneously addressing both somatic and psychological needs in patients with IBS as early as possible.

Entities:  

Mesh:

Year:  2016        PMID: 27377523     DOI: 10.1038/ajg.2016.255

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  50 in total

1.  [On the problem of missing data: How to identify and reduce the impact of missing data on findings of data analysis].

Authors:  M Wirtz
Journal:  Rehabilitation (Stuttg)       Date:  2004-04       Impact factor: 1.113

Review 2.  Systematic review: the epidemiology and clinical features of travellers' diarrhoea.

Authors:  H L DuPont
Journal:  Aliment Pharmacol Ther       Date:  2009-04-21       Impact factor: 8.171

3.  Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up.

Authors:  Viola Andresen; Bernd Löwe; Wiebke Broicher; Björn Riegel; Katharina Fraedrich; Moritz von Wulffen; Kerrin Gappmayer; Karl Wegscheider; András Treszl; Matthias Rose; Peter Layer; Ansgar W Lohse
Journal:  United European Gastroenterol J       Date:  2015-04-28       Impact factor: 4.623

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Postinfectious irritable bowel syndrome--a meta-analysis.

Authors:  Heather A Halvorson; Carey D Schlett; Mark S Riddle
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

6.  The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study.

Authors:  N A Koloski; M Jones; J Kalantar; M Weltman; J Zaguirre; N J Talley
Journal:  Gut       Date:  2012-01-10       Impact factor: 23.059

7.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

8.  Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS.

Authors:  Jeffrey M Lackner; Gregory D Gudleski; Chang-Xing Ma; Akriti Dewanwala; Bruce Naliboff
Journal:  Am J Gastroenterol       Date:  2014-09-16       Impact factor: 10.864

9.  Life course study of the etiology of self-reported irritable bowel syndrome in the 1958 British birth cohort.

Authors:  Laura Goodwin; Peter D White; Matthew Hotopf; Stephen A Stansfeld; Charlotte Clark
Journal:  Psychosom Med       Date:  2013-01-16       Impact factor: 4.312

10.  An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome.

Authors:  Robin Spiller; Ching Lam
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

View more
  10 in total

1.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

Review 2.  To learn, to remember, to forget-How smart is the gut?

Authors:  Michael Schemann; Thomas Frieling; Paul Enck
Journal:  Acta Physiol (Oxf)       Date:  2019-06-05       Impact factor: 6.311

3.  Ratio of Omega-6/Omega-3 Polyunsaturated Fatty Acids Associated With Somatic and Depressive Symptoms in People With Painful Temporomandibular Disorder and Irritable Bowel Syndrome.

Authors:  Anne E Sanders; E Diane Weatherspoon; Brandie M Ehrmann; Paul S Soma; Saame R Shaikh; John S Preisser; Richard Ohrbach; Roger B Fillingim; Gary D Slade
Journal:  J Pain       Date:  2022-04-25       Impact factor: 5.383

4.  Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).

Authors:  Bernd Löwe; Yvonne Nestoriuc; Viola Andresen; Eik Vettorazzi; Antonia Zapf; Sina Hübener; Kerstin Maehder; Luisa Peters; Ansgar W Lohse
Journal:  BMJ Open       Date:  2022-06-14       Impact factor: 3.006

5.  Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care - a long-term, population-based study.

Authors:  Chalotte Heinsvig Poulsen; Lene Falgaard Eplov; Carsten Hjorthøj; Marie Eliasen; Sine Skovbjerg; Thomas Meinertz Dantoft; Andreas Schröder; Torben Jørgensen
Journal:  Clin Epidemiol       Date:  2017-07-31       Impact factor: 4.790

6.  Approach to stress endocrine response: somatization in the context of gastroenterological symptoms: a systematic review.

Authors:  Gülseren Keskin
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

7.  Intrinsic brain abnormalities of irritable bowel syndrome with diarrhea: a preliminary resting-state functional magnetic resonance imaging study.

Authors:  Weiqun Ao; Yougen Cheng; Mingxian Chen; Fuquan Wei; Guangzhao Yang; Yongyu An; Fan Mao; Xiandi Zhu; Guoqun Mao
Journal:  BMC Med Imaging       Date:  2021-01-06       Impact factor: 1.930

Review 8.  Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Authors:  Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco
Journal:  Foodborne Pathog Dis       Date:  2019-10-07       Impact factor: 3.788

9.  Persistent SOMAtic symptoms ACROSS diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211).

Authors:  Meike Shedden-Mora; Anne Toussaint; Bernd Löwe; Viola Andresen; Omer Van den Bergh; Tobias B Huber; Olaf von dem Knesebeck; Ansgar W Lohse; Yvonne Nestoriuc; Gudrun Schneider; Stefan W Schneider; Christoph Schramm; Sonja Ständer; Eik Vettorazzi; Antonia Zapf
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

10.  Early Psychological Interventions for Somatic Symptom Disorder and Functional Somatic Syndromes: A Systematic Review and Meta-Analysis.

Authors:  Lukas Berezowski; Lea Ludwig; Alexandra Martin; Bernd Löwe; Meike C Shedden-Mora
Journal:  Psychosom Med       Date:  2022-04-01       Impact factor: 4.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.